• 1
    Fausto N, Laird AD, Webber EM. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995; 9: 15271536.
  • 2
    Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990; 4: 176187.
  • 3
    Friedman SL, Millward-Sadler GH, Arthur JP. Liver fibrosis and cirrhosis. In: Millward-SadlerWA, ed. Wright's Liver and Biliary Disease. Vol. 2. London: Saunders, 1992: 821881.
  • 4
    Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med 1993; 328: 18281835.
  • 5
    Bishop GA, Rokahr KL, Napoli J, McCaughan GW. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcriptase-PCR. Transplant Immunol 1993; 1: 253261.
  • 6
    Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annals of Biochemistry 1987; 162: 156158.
  • 7
    Napoli J, Bishop GA, McGuiness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24: 759765.
  • 8
    Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vas-cularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493496.
  • 9
    Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984; 65: 305311.
  • 10
    Zimmermann H, Ganz P, Zimmermann A, Oguey D, Marti U, Reichen J. The overexpression of proliferating nuclear cell antigen in biliary cirrhosis in the rat and its relationship with epidermal growth factor receptor. J Hepatol 1995; 23: 459464.
  • 11
    Marucci L, Baroni GS, Mancini R, Benedetti A, Jezequel AM, Orlandi F. Cell proliferation following extrahepatic biliary obstruction. J Hepatol 1993; 17: 163169.
  • 12
    Baird A, Esch F, Mormede P, Ueno N, Ling N, Bohlen P, Ying SY, et al. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog Horm Res 1986; 42: 143205.
  • 13
    Nagasaki T, Lieberman MA. Liver contains heparin-binding growth factors as the major growth factor for cultured fibroblasts. Hepatology 1991; 13: 614.
  • 14
    Charlotte F, Win KM, Preaux AM, Mavier P, Dhumeaux D, Zafrani ES, Rosenbaum J, et al. Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol 1993; 169: 471476.
  • 15
    Bishop GA, Matsumoto Y, McCaughan GW, Kenney JS. Identification of cytokine protein expression in human liver allograft rejection: methods development and expression of IL-1β, IL-6, IFN-γ and basic fibroblast growth factor. Transplant Proc 1992; 24: 23102312.
  • 16
    Presta M, Statute M, Rusnati M, Dell'Era P, Ragnotti G. Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. Biochem Biophys Res Commun 1989; 164: 11821189.
  • 17
    Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 17861793.
  • 18
    Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 575606.
  • 19
    Rappaport AM, MacPhee PJ, Fisher MM, Philips MJ. The scarring of the liver acini (cirrhosis). Virchows Arch A (Pathol Anat) 1983; 402: 107137.
  • 20
    Marti U, Burwen SJ, Jones AL. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 1989; 9: 126138.
  • 21
    Mullhaupt B, Feren A, Fodor E, Jones A. Liver expression of epidermal growth factor RNA. Rapid increases in immediate-early phase of liver regeneration. J Biol Chem 1994; 269: 1966719670.
  • 22
    Noguchi S, Ohba Y, Oka T. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinol 1991; 128: 425431.
  • 23
    Earp HS, O'Keefe EJ. Epidermal growth factor receptor number decreases during rat liver regeneration. J Clin Invest 1981; 67: 15801583.
  • 24
    St. Hiliare RJ, Hradek GT, Jones AL. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high capacity uptake system. Proc Natl Acad Sci U S A 1983; 80: 37973801.
  • 25
    Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin–6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 1994; 20: 376382.
  • 26
    Bachem MG, Reiss U, Gressner AM. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun 1989; 162: 708714.
  • 27
    Oguey D, Marti U, Reichen J. Epidermal growth factor receptor in chronic bile duct obstructed rats: implications for maintenance of hepa-tocellular mass. Eur J Cell Biol 1992; 59: 187195.
  • 28
    Derynck R. Transforming growth factor alpha. Cell 1988; 54: 593595.
  • 29
    Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci U S A 1989; 86: 15581562.
  • 30
    Flanders KC. Transforming growth factor-β and the fibrotic response. In: GressnerAM, RamadoriG, eds. Molecular and Cell Biology of Liver Fibrogenesis. Dordrecht: Kluwer Academic Publishers, 1992: 241253.
  • 31
    Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991; 139: 12211229.
  • 32
    Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy [Comments]. N Engl J Med 1991; 324: 933940.
  • 33
    Napoli J, Bishop GA, McCaughan GW. Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastro-enterology 1994; 107: 789798.
  • 34
    Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type B transforming growth factor. Cancer Res 1986; 46: 23302334.
  • 35
    Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci U S A 1988; 85: 15391543.
  • 36
    Mitsue S, Hamanoue M, Tanabe G, Ogura Y, Yoshdome S, Aikou T, Nakamura T, et al. Expression of HGF and TGF-beta 1 mRNA after partial hepatectomy in rats with liver cirrhosis. Surg Today 1995; 25: 237243.
  • 37
    Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991; 13: 743750.
  • 38
    Joplin R, Hishida T, Tsubouchi H, Daikuhara Y, Ayres R, Neuberger JM, Strain AJ, et al. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest 1992; 90: 12841289.
  • 39
    Michalopoulos GK, Zarnegar R. Hepatocyte growth factor. Hepatology 1992; 15: 149155.
  • 40
    Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992; 15: 511.
  • 41
    Matsumoto K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte gene expression in human lung fibroblasts and leukaemic cells by transforming growth factor-β1 and glucocorticoids. J Biol Chem 1992; 267: 2491724920.